A problem of multiple drug overdose by patient with schizophrenia - case report

Anna Katarzyna Orzeł, Barbara Klatka, Dominika Janeczko, Magdalena Hołowczuk, Michał Terpiłowski, Michał Tchórz

Abstract


Introduction
Suicidal risk caused by drug overdose is a considerable factor influencing earlier mortality among people with schizophrenia. An adjustment of effective pharmacological treatment is essential to sustain the stability of the patient. Commonly, the treatment divides to two groups: first generation antipsychotics (FGA) and second-generation antipsychotics (SGA). Yet, due to significant risk of depression and possible side effects of the drugs, other medicaments should also be introduced.

Case report
A 38 years old woman that was repeatedly hospitalized at the local ward, brought by ambulance and admitted to the Clinical Toxicology Department. She was admitted to the department for 20th time in period between April 2013 and May 2019 due to deliberate drug overdoses. During last hospitalization laboratory tests indicated presence of valproic acid (121,41 μg/ml). Moreover, psychiatric consultation revealed that although she was balanced state, she was not critical about her behavior. Patient was diagnosed with schizophrenia and mild intellectual disability. Each time, the intoxication was followed by medications from group of antipsychotics and tranquilizers used in treatment of the illness. Additionally, she confirmed that some of intoxications had suicidal attempt. 60% of hospitalizations of the patient were followed by stay in Neuropsychiatric hospital for further observation and treatment.

Conclusion
The administration of proper dosage of antipsychotics should be precisely controlled by the psychiatrist that takes care of the patient. For patients with greater suicidal risk, SGA are more recommended than FGA. Moreover, drugs from other groups such as antidepressants should also be introduced. Undoubtedly, efficient pharmacological treatment should be supported by psychotherapy of the patient.

Keywords


drug overdose; schizophrenia; antipsychotics; suicide

Full Text:

PDF

References


Kopala L, Day C, Dillman B, Gardner D. A case of risperidone overdose in early schizophrenia: a review of potential complications (1998) J Psychiatry Neurosci, 305-8.

Schizofrenia. Perspektywa społeczna, sytuacja w Polsce. accessed at: www_janssen_com_polandfileraport_schizofrenia_perspektywa_spoleczna._sytuacja_w_polsce.pdf (20.05.2019).

Mayo Clinic, Schizophrenia, accessed: https://www.mayoclinic.org/diseases-conditions/schizophrenia/symptoms-causes/syc-20354443 (20.05.2019).

Sayantanava M, Mahintamani T, Kavoor AR, Nizamie SH. Negative symptoms in schizophrenia, Ind Psychiatry J. 2016 Jul-Dec; 25(2): 135–144.

Pierre, JM (2005). "Extrapyramidal symptoms with atypical antipsychotics: incidence, prevention and management". Drug Safety. 28 (3): 191–208.

Lally J, MacCabe JH, Antipsychotic medication in schizophrenia: a review, British Medical Bulletin (2015), 114(1):169–179.

Medycyna Praktyczna, Postępowanie dotyczące długoterminowego leczenia chorych na schizofrenię oraz zasad postępowania w przypadkach wystąpienia powikłań terapii przeciwpsychotycznej, accessed at: https://www.mp.pl/poz/psychiatria/zaburzenia_lekowe/111420,postepowanie-dotyczace-dlugoterminowego-leczenia-chorych-na-schizofrenie-oraz-zasad-postepowania-w-przypadkach-wystapienia-powiklan-terapii-przeciwpsychotycznej (21.05.2019).

De Hert M, Sermon J, Geerts P, Vansteelandt K, Peuskens J, Detraux J. The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics. CNS Drugs (2015), 29(8):637-58.

Bilikiewicz A, Pużyński S, Wciórka J, Rybakowski J: Psychiatria. T. 3. Wrocław: Urban & Parner, 2003.

Meltzer HY, Alphs L, Green AL,; et al. Clozapine Treatment for Suicidality in Schizophrenia. Arch Gen Psychiatry (2003), 60(1):82-91.

American Psychiatric Association practice guidelines for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry (2003), 160(11): 1-60.

Sztajnkrycer MD, Valproic Acid Toxicity: Overview and Management. Journal of Toxicology: Clinical Toxicology (2002), 40(6), 789–801.

Schotte, A; Janssen PF; Megens AA; Leysen JE, Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research (1993), 631 (2): 191–202.

Kasper, Siegfried; Müller-Spahn, Franz, Review of quetiapine and its clinical applications in schizophrenia. Expert Opinion on Pharmacotherapy (2005), 1 (4): 783–801.

Calcaterra, NE; Barrow, JC, Classics in chemical neuroscience: diazepam (valium). ACS Chemical Neuroscience (2019) 5 (4): 253–60.

Siris S, Suicide and schizophrenia, Journal of Psychopharmacology (2001), 15(2): 127135.

Pretia A, Miotto P, Seasonality in suicides: the influence of suicide method, gender and age on suicide distribution in Italy, Psychiatry Research (1998), 81(2), 219-231.

Kenneth S, McCleary C, The spring peak in suicides: A cross-national analysis, Social Science & Medicine (1995), 40(2), 223-230.

Micallef J, Fakra E, Blin O, Use of antidepressant drugs in schizophrenic patients with depression, L'Encephale (2006), 32(2):263-269.

Reves JG, Fragen RJ, Vinik HR, Greenblatt DJ, Midazolam: pharmacology and uses, Anesthesiology 1985, 62(3):310-324.

K. T. Olkkola, J. Ahonen, Midazolam and Other Benzodiazepines, Modern Anesthetics pp 335-360.




DOI: http://dx.doi.org/10.5281/zenodo.3373971

Refbacks

  • There are currently no refbacks.




Copyright (c) 2019 © The Author(s)

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Journal of Education, Health and Sport formerly Journal of Health Sciences

Declaration on the original version.

Editors indicates that the main version of the magazine is to issue a "electronic".

The journal has had 5 points in Ministry of Science and Higher Education parametric evaluation. § 8. 2) and § 12. 1. 2) 22.02.2019.

1223 Journal of Education, Health and Sport eISSN 2391-8306 7

ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

Archives 2011 - 2014

PBN 2011 - 2014

https://pbn.nauka.gov.pl/sedno-webapp/search?search&searchCategory=WORK&filter.inJournal=36616

POL-index 2011 - 2014

https://pbn.nauka.gov.pl/polindex-webapp/browse/journal/journal-32a319c5-a850-4f44-ba70-1418a6087655

BASE 2011 - 2014

https://www.base-search.net/Search/Results?lookfor=Journal+of+Health+Sciences+%28Radom%29&type=all&oaboost=1&ling=1&name=&thes=&refid=dcrespl&newsearch=1

http://elibrary.ru/contents.asp?titleid=37467

http://journal.rsw.edu.pl/index.php/JHS/issue/archive

Indexed in Bases, Bazy indeksacyjne: ERIH Plus, Worldcat, PBN/POL-Index, ICI Journals Master List, Directory of Open Access Journals (DOAJ), ZBD, Ulrich's periodicals, Google Scholar, Polska Bibliografia Lekarska

US NLM = 101679844

101679844 - NLM Catalog Result - NCBI

https://www.ncbi.nlm.nih.gov/nlmcatalog/101679844

Find a library that holds this journal: http://worldcat.org/issn/23918306

Journal Language(s): English 

PBN Poland

https://pbn.nauka.gov.pl/sedno-webapp/journals/49068

POL-index

https://pbn.nauka.gov.pl/polindex-webapp/browse/journal/journal-c39c8169-88d2-45db-9e7f-d948ce9981c4

BASE

https://www.base-search.net/Search/Results?join=AND&bool0[]=AND&lookfor0[]=2391-8306&type0[]=all&page=11&l=pl&oaboost=1&refid=dcpagepl

Redaction, Publisher and Editorial Office

Instytut Kultury Fizycznej Uniwersytet Kazimierza Wielkiego w Bydgoszczy, Institute of Physical Education Kazimierz Wielki University in Bydgoszcz, Poland 85-091 Bydgoszcz ul. Sportowa 2  www.ukw.edu.pl Copyright by Instytut Kultury Fizycznej UKW w Bydgoszczy http://ojs.ukw.edu.pl/index.php/johs  Open Access ISSN 2391-8306 formerly ISSN: 1429-9623 / 2300-665X

The journal has been approved for inclusion in ERIH PLUS.

The ERIH PLUS listing of the journal is available at https://dbh.nsd.uib.no/publiseringskanaler/erihplus/periodical/info?id=485984

SIC Science citation index (calculated on the basis of TCI and Page Rank) 0

Russian Impact factor 0.16

Indexed in Index Copernicus Journals Master List.

http://journals.indexcopernicus.com/Journal+of+Education+Health+and+Sport,p24782242,3.html

ICV 2018 = 95.95 ICV 2017 = 91.30 ICV 2016 = 84.69 ICV 2015 = 93.34 ICV 2014 = 89.51 Standardized Value: 8.27 ICV 2013: 7.32 ICV 2012: 6.41 ICV 20115.48

The InfoBase Index IBI Factor for the year 2015 is 3.56 in InfoBase Index.com.

Website: www.infobaseindex.com

Universal Impact Factor 1.78 for year 2012. (http://www.uifactor.org/AppliedJournals.aspx)

Indexed in Polish Scholarly Bibliography (PBN) (PBN Polska Bibliografia Naukowa) (https://pbn.nauka.gov.pl/journals/36616)

is a portal of the Polish Ministry of Science and Higher Education, collecting information on publications of Polish scientists and on Polish and foreign scholarly journals. Polish Scholarly Bibliograhpy is a part of POL-on - System of Information on Higher Education. It is operated by the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw.

Indexed in Russian Sciences Index Российский индекс научного цитирования (РИНЦ) http://elibrary.ru/contents.asp?titleid=37467

Indexed in Arianta Polish scientific and professional electronic journals Aneta Drabek i Arkadiusz Pulikowski

(http://www1.bg.us.edu.pl/bazy/czasopisma/czasop_full.asp?id=3595)